Verve Therapeutics Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	164.7	9.39	3.68	-
Cash & Short-Term Investments	164.7	9.39	3.68	-
Cash Growth	-	154.90%	-	-
Accounts Receivable	139.51	103.78	102.06	-
Other Receivables	21.94	11.4	21.88	-
Receivables	161.45	115.88	124.71	-
Inventory	348.42	392.17	475.92	-
Prepaid Expenses	-	9.51	2.39	-
Restricted Cash	5.44	81.96	13.43	-
Other Current Assets	-	1.08	25.81	-
Total Current Assets	680	609.98	645.94	-
Property, Plant & Equipment	19.87	17.1	9.67	-
Long-Term Investments	117.2	108.87	53.07	-
Other Intangible Assets	3.57	3.57	3.57	-
Long-Term Deferred Tax Assets	8.11	7.65	2.39	-
Other Long-Term Assets	475.57	454.44	319.9	-
Total Assets	1,346	1,240	1,067	-
Accounts Payable	66.62	45.34	37.73	-
Accrued Expenses	13.74	59.23	30.87	-
Short-Term Debt	-	0.01	-	-
Current Portion of Long-Term Debt	429.61	506.46	464.25	-
Current Income Taxes Payable	6.33	2.65	1.87	-
Current Unearned Revenue	98.01	119.33	54.4	-
Other Current Liabilities	35.91	34.41	34.73	-
Total Current Liabilities	650.22	767.41	623.85	-
Long-Term Debt	279.98	137.07	117.2	-
Long-Term Leases	2.03	1.48	0.58	-
Long-Term Deferred Tax Liabilities	14.55	11.81	8.22	-
Other Long-Term Liabilities	1	2	-	-
Total Liabilities	948.09	920.08	750.06	-
Common Stock	71.46	0	0	-
Retained Earnings	326.14	320.1	317.34	-
Shareholders' Equity	397.59	320.1	317.34	-
Total Liabilities & Equity	1,346	1,240	1,067	-
Total Debt	711.62	645.01	582.03	-
Net Cash (Debt)	-546.92	-635.62	-578.35	-
Net Cash Per Share	-269.15	-3026.78	-2754.04	-
Filing Date Shares Outstanding	50.32	50.47	0.21	0.21
Total Common Shares Outstanding	50.32	50.47	0.21	0.21
Working Capital	29.78	-157.43	22.09	-
Book Value Per Share	7.90	6.34	1511.14	-
Tangible Book Value	394.03	316.54	313.77	-
Tangible Book Value Per Share	7.83	6.27	1494.16	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.